18th PMP Quarterly Report: FATA Institutional Strengthening Project

The project is being implemented through Abacus Consulting under Contract # AID-391-C-11-00003, with funding from the United States Agency for International Development (USAID). During the 18th quarter, the FISP team worked in close coordination with FS and FDA to achieve the project targets assigned for this quarter. Progress was made against several indicators, including the percentage of trained FS and FDA employees using new or improved systems. A total of 99% of trained employees were using the newly developed systems, although four systems were found to be relatively underutilized. The project also provided assistance to 26 sub-national government entities to improve their performance, exceeding the target of 26 entities. Additionally, 10 government operations were supported with USG assistance, meeting the target of 10 operations. These operations included project planning and proposal development, information technology support services, and monitoring and evaluation. The FISP training program conducted 23 trainings, exceeding the target of 20 trainings. A total of 385 officials were trained, surpassing the target of 370 officials. The trainings covered various topics, including the Public Procurement Management System, the Financial Assistance Management System, and the Human Resource Management Information System. The project also provided IT support to 19 entities, meeting the target of 19 entities. All FS departments and directorates were provided with internet, intranet, and VoIP facilities. The FISP team worked closely with FS and FDA to achieve the project targets, and progress was made against several indicators during the 18th quarter. The FISP aims to continue strengthening the institutional capacity of FS and FDA through systems development and trainings imparted. The project's success is evident in the progress made against the indicators, and it is expected to continue making a positive impact on the functional capacity of FS and FDA.